ResMed, Inc. (RMD) Misses Q3 EPS by 1c

ResMed, Inc. (NYSE: RMD) reported Q3 EPS of $0.63, $0.01 worse than the analyst estimate of $0.64. Revenue for the quarter came in at $397.8 million versus the consensus estimate of $401 million.

For earnings history and earnings-related data on ResMed, Inc. (RMD) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• Deere (DE) PT Lowered to $570 at JPMorgan Ahead of Earnings